A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophilsVictoria Ozberk, Manisha Pandey, Glen C. Ulett et al.|Nature Communications|2023Cited by 19
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteersVanessa Meier‐Stephenson, Maryna Yaskina, Michael Hawkes et al.|Trials|2024Cited by 12
Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infectionJamie‐Lee Mills, Manisha Pandey, Ailin Lepletier et al.|Frontiers in Immunology|2024Cited by 7
Disruption of IL-17 signaling in the respiratory mucosa results in invasive streptococcal infectionJamie‐Lee Mills, Manisha Pandey, Ailin Lepletier et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0
Parenteral Vaccination with a Super Immunogen Targeting M-Protein Provides Unprecedented Protection Against Group A Streptococcus (StrepA) Respiratory InfectionsVictoria Ozberk, Manisha Pandey, Christie Short et al.|Unknown|2025Cited by 0